Aquestive Therapeutics Reports Positive Results from Latest

Time to maximum blood concentration for Anaphylm was 10 minutes with a range of 5 to 20 minutesEarly drug exposure at 10 minutes for Anaphylm was similar to Auvi-Q® auto-injector 0.3mg and over... | May 31, 2023

Related Keywords

United States , Stephanie Carrington , Daniel Barber , Nasdaq , Exchange Commission , Aquestive Therapeutics Inc , Belcher Pharmaceuticals , Single Administration Pilot Pk Study , Company Or Aquestive , Professor Of Medicine At Johns Hopkins University , Linkedin , Chief Executive Officer , Associate Professor , Johns Hopkins University , Comparing Different Auto Injectors , Manual Injection , Repeat Dose , Teva Pharmaceutical United States , Private Securities Litigation Reform Act , Sublingual Film , Annual Report , Quarterly Reports , Current Reports , Current Report , Aquestive Therapeutics , Nc Stock Exchange , News , Information , Press Release , Dime , O , Maximum , Flood , Concentration , Or , Naphylm , Gas , 0 , Inutes , Ith , Orange , F , , Inutesearly , Drug , Exposure , It , Similar , Nd Aqst Us03843e1047 ,